Serum Ghrelin in Polycystic Ovary Syndrome

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Not yet recruiting

Clinical Trial Summary

measuring serum gherlin in polycystic ovary syndrome patients and compare it to healthy levels

two groups one healthy and other with pco measure ghrelin level in both of them to find relation between pco and ghrelin ;

Observational Model: Case Control, Time Perspective: Cross-Sectional

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05965908` - Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome	Phase 3
Recruiting	`NCT03819998` - Serum Fetuin Level in Polycystic Ovary Syndrome
Completed	`NCT04231786` - Breast Ultrasonography and Polycystic Ovary Syndrome
Completed	`NCT04448730` - Polycystic Ovary Syndrome and BETATROPHIN
Completed	`NCT05062135` - Progesterone Action on Endometrium of PCOS	N/A
Recruiting	`NCT03178500` - Clomiphene Citrate Stair-Step Protocol	N/A
Completed	`NCT03871868` - Vitamin D Levels And Myoma Uteri
Recruiting	`NCT05452642` - The Supporting Understanding of PCOS Education and Research (SUPER) Study	N/A